The assessment of @entity5 angiogenesis in @entity1149 is presently a subject of intensive research with potential clinical applications. In this study, the expression of @entity7 and @entity319 was examined by immunohistochemistry in 67 @entity5 samples obtained from @entity1149 @entity1 treated by radical resection. Distribution of age, sex, @entity5 stage and histology was typical for @entity1 population in Poland. @entity7 expression (more than 25% of positive cells) was noted in 65% of @entity5 cells. @entity319 expression was observed in 91% of @entity5 cells. Neither the number of positive cells nor the staining intensity correlated with the clinical variables (all p values >0.05, chi-square test). No correlation was noted between the expression of @entity7 and @entity319 (p=0.35, chi-square test). In survival analysis, neither the number of positive cells nor the staining intensity of both molecules was of prognostic significance. The expression of @entity7 and @entity319 in @entity1149 cells was confirmed in this study. The relation to clinical variables and survival will be further assessed in a larger group of @entity1 .

Expression of XXXX ( @entity7 ) and its receptor @entity319 in @entity1149 ( @entity1149 )--a preliminary report.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity7 :: ('7422', 'Gene') :: ['VEGF'] @entity5 :: ('MESH:D009369', 'Disease') :: ['archival tumour', 'tumour'] @entity1149 :: ('MESH:D002289', 'Disease') :: ['NSCLC'] @entity319 :: ('3791', 'Gene') :: ['FLK-1']
@entity7 :: (7422,Gene) :: ['vascular endothelial growth factor']
